Royalderm Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services

Secondary Activities: Cosmetics, Beauty Supplies, and Perfume Stores | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | General Medical and Surgical Hospitals

Full name: Royalderm Sp. z o.o.

Profile Updated: May 28, 2024

Royalderm Sp. z o.o. is an enterprise based in Poland. Its main office is in Warsaw. It operates in the Ambulatory Health Care Services sector. The enterprise was incorporated on January 26, 2022. In 2025, the company reported a net sales revenue drop of 8.91%. During that time, Royalderm Sp. z o.o.’s total assets decreased by 44.89%.

Headquarters
Ul. Krzysztofa Kieslowskiego 3B/3
Warsaw; Mazowieckie; Postal Code: 02-962

Contact Details: Purchase the Royalderm Sp. z o.o. report to view the information.

Basic Information

Registered Capital:

Purchase the Royalderm Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Royalderm Sp. z o.o. report to view the information.

Incorporation Date:

January 26, 2022

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Royalderm Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

-8.91%▼

Total Operating Revenue

-8.91%▼

Operating Profit

N/A

Net Profit/Loss for the Period

N/A

Total Assets

-44.89%▼

Total Equity

-65.76%▼

Operating Profit Margin

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

N/A

Quick Ratio

-0.72%▼

Cash Ratio

-0.77%▼

Similar companies

Related EMIS Industry Reports